182 related articles for article (PubMed ID: 25818840)
1. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Tzeng CH
Br J Haematol; 2015 Jun; 169(5):737-45. PubMed ID: 25818840
[TBL] [Abstract][Full Text] [Related]
2. Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patients.
Liu YC; Gau JP; Hong YC; Yu YB; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
Ann Hematol; 2012 Dec; 91(12):1953-8. PubMed ID: 22869091
[TBL] [Abstract][Full Text] [Related]
3. Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients.
Rhodes M; Lautz T; Kavanaugh-Mchugh A; Manes B; Calder C; Koyama T; Liske M; Parra D; Frangoul H
Bone Marrow Transplant; 2005 Jul; 36(2):139-44. PubMed ID: 15908968
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.
Labrador J; López-Corral L; Vazquez L; Sánchez-Guijo F; Guerrero C; Sánchez-Barba M; Lozano FS; Alberca I; Del Cañizo MC; Caballero D; González-Porras JR
Br J Haematol; 2015 Jun; 169(5):719-25. PubMed ID: 25817436
[TBL] [Abstract][Full Text] [Related]
5. Factors Affecting Survival in Children With Pericardial Effusion After Hematopoietic Stem Cell Transplantation.
Jaing TH; Chen SH; Wen YC; Chang TY; Tsai DY; Chung HT; Tsay PK
Cell Transplant; 2017 Nov; 26(11):1792-1797. PubMed ID: 29338379
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study of risk factors for pericardial effusion after haematopoietic stem cell transplantation in children.
Tong K; Meng Y; Zhang L; Lei X; Guan X; Xiao L; Yu J; Dou Y
Hematology; 2023 Dec; 28(1):2245259. PubMed ID: 37551721
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Outcome of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplant: A Single-institution Experience.
Diamond M; Ruiz-Mesa C; Corrales-Medina FF; Tamariz LJ; Ziga E; Swaminathan S
J Pediatr Hematol Oncol; 2018 Mar; 40(2):132-136. PubMed ID: 28945662
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation.
Kubo H; Imataki O; Fukumoto T; Oku M; Ishida T; Kubo YH; Kida JI; Uemura M; Fujita H; Ohno H; Ide M; Ohnishi H; Kadowaki N
Transplant Cell Ther; 2021 Nov; 27(11):949.e1-949.e8. PubMed ID: 34333179
[TBL] [Abstract][Full Text] [Related]
9. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
10. Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes.
Tinianow A; Gay JC; Bearl DW; Connelly JA; Godown J; Kitko CL
Pediatr Transplant; 2020 Aug; 24(5):e13748. PubMed ID: 32485042
[TBL] [Abstract][Full Text] [Related]
11. Predictors and Outcome of Pericardial Effusion After Hematopoietic Stem Cell Transplantation in Children.
Versluys AB; Grotenhuis HB; Boelens MJJ; Mavinkurve-Groothuis AMC; Breur JMPJ
Pediatr Cardiol; 2018 Feb; 39(2):236-244. PubMed ID: 29058031
[TBL] [Abstract][Full Text] [Related]
12. Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation.
Martínez-Bravo MJ; Calderón-Cabrera C; Márquez-Malaver FJ; Rodríguez N; Guijarro M; Espigado I; Núñez-Roldán A; Pérez-Simón JA; Aguilera I
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1356-62. PubMed ID: 24844856
[TBL] [Abstract][Full Text] [Related]
13. Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation.
Matin A; Smith BH; Mangaonkar A; Duffy DJ; Wolf R; Alkhateeb H; Shah MV; Hogan WJ; Litzow MR
Transplant Cell Ther; 2023 May; 29(5):324.e1-324.e6. PubMed ID: 36682472
[TBL] [Abstract][Full Text] [Related]
14. Pericardial effusion after pediatric hematopoietic cell transplant.
Aldoss O; Gruenstein DH; Bass JL; Steinberger J; Zhang Y; Defor TE; Tolar J; Verneris MR; Orchard PJ
Pediatr Transplant; 2013 May; 17(3):294-9. PubMed ID: 23464863
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
17. Pericardial Effusion Following Hematopoietic Cell Transplantation in Children and Young Adults Is Associated with Increased Risk of Mortality.
Cox K; Punn R; Weiskopf E; Pinsky BA; Kharbanda S
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1165-1169. PubMed ID: 28390986
[TBL] [Abstract][Full Text] [Related]
18. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
[TBL] [Abstract][Full Text] [Related]
19. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
